S&P 500   3,168.57 (+0.86%)
DOW   28,132.05 (+0.79%)
QQQ   206.51 (+0.75%)
AAPL   271.46 (+0.25%)
FB   196.75 (-2.72%)
MSFT   153.24 (+1.02%)
GOOGL   1,348.49 (+0.32%)
AMZN   1,760.33 (+0.66%)
CGC   21.13 (+4.35%)
NVDA   224.32 (+3.21%)
MU   50.97 (+3.47%)
BABA   204.50 (-0.07%)
GE   11.44 (+4.28%)
TSLA   359.68 (+1.98%)
T   38.35 (+0.47%)
AMD   42.59 (+7.90%)
ACB   2.60 (+6.12%)
F   9.32 (+2.31%)
PRI   136.50 (+0.78%)
NFLX   298.50 (-0.14%)
BAC   34.68 (+3.09%)
GILD   67.63 (-0.22%)
DIS   147.76 (+0.12%)
S&P 500   3,168.57 (+0.86%)
DOW   28,132.05 (+0.79%)
QQQ   206.51 (+0.75%)
AAPL   271.46 (+0.25%)
FB   196.75 (-2.72%)
MSFT   153.24 (+1.02%)
GOOGL   1,348.49 (+0.32%)
AMZN   1,760.33 (+0.66%)
CGC   21.13 (+4.35%)
NVDA   224.32 (+3.21%)
MU   50.97 (+3.47%)
BABA   204.50 (-0.07%)
GE   11.44 (+4.28%)
TSLA   359.68 (+1.98%)
T   38.35 (+0.47%)
AMD   42.59 (+7.90%)
ACB   2.60 (+6.12%)
F   9.32 (+2.31%)
PRI   136.50 (+0.78%)
NFLX   298.50 (-0.14%)
BAC   34.68 (+3.09%)
GILD   67.63 (-0.22%)
DIS   147.76 (+0.12%)
S&P 500   3,168.57 (+0.86%)
DOW   28,132.05 (+0.79%)
QQQ   206.51 (+0.75%)
AAPL   271.46 (+0.25%)
FB   196.75 (-2.72%)
MSFT   153.24 (+1.02%)
GOOGL   1,348.49 (+0.32%)
AMZN   1,760.33 (+0.66%)
CGC   21.13 (+4.35%)
NVDA   224.32 (+3.21%)
MU   50.97 (+3.47%)
BABA   204.50 (-0.07%)
GE   11.44 (+4.28%)
TSLA   359.68 (+1.98%)
T   38.35 (+0.47%)
AMD   42.59 (+7.90%)
ACB   2.60 (+6.12%)
F   9.32 (+2.31%)
PRI   136.50 (+0.78%)
NFLX   298.50 (-0.14%)
BAC   34.68 (+3.09%)
GILD   67.63 (-0.22%)
DIS   147.76 (+0.12%)
S&P 500   3,168.57 (+0.86%)
DOW   28,132.05 (+0.79%)
QQQ   206.51 (+0.75%)
AAPL   271.46 (+0.25%)
FB   196.75 (-2.72%)
MSFT   153.24 (+1.02%)
GOOGL   1,348.49 (+0.32%)
AMZN   1,760.33 (+0.66%)
CGC   21.13 (+4.35%)
NVDA   224.32 (+3.21%)
MU   50.97 (+3.47%)
BABA   204.50 (-0.07%)
GE   11.44 (+4.28%)
TSLA   359.68 (+1.98%)
T   38.35 (+0.47%)
AMD   42.59 (+7.90%)
ACB   2.60 (+6.12%)
F   9.32 (+2.31%)
PRI   136.50 (+0.78%)
NFLX   298.50 (-0.14%)
BAC   34.68 (+3.09%)
GILD   67.63 (-0.22%)
DIS   147.76 (+0.12%)
Log in

NASDAQ:MOTS - Motus GI Stock Price, Forecast & News

$2.45
0.00 (0.00 %)
(As of 12/12/2019 04:00 PM ET)
Today's Range
$2.40
Now: $2.45
$2.60
50-Day Range
$1.53
MA: $1.77
$2.44
52-Week Range
$1.43
Now: $2.45
$4.99
Volume94,419 shs
Average Volume91,512 shs
Market Capitalization$70.55 million
P/E RatioN/A
Dividend YieldN/A
Beta1.52
Motus GI Holdings, Inc operates as a medical technology company to enhance the endoscopy outcomes and experiences in the United States and Israel. It focuses on the development and commercialization of the Pure-Vu system to enhance the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:MOTS
CUSIPN/A
Phone954-541-8000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$40,000.00
Book Value$0.86 per share

Profitability

Net Income$-22,260,000.00

Miscellaneous

Employees44
Market Cap$70.55 million
Next Earnings Date3/25/2020 (Estimated)
OptionableNot Optionable

Receive MOTS News and Ratings via Email

Sign-up to receive the latest news and ratings for MOTS and its competitors with MarketBeat's FREE daily newsletter.


Motus GI (NASDAQ:MOTS) Frequently Asked Questions

What is Motus GI's stock symbol?

Motus GI trades on the NASDAQ under the ticker symbol "MOTS."

How were Motus GI's earnings last quarter?

Motus GI Holdings Inc (NASDAQ:MOTS) released its quarterly earnings data on Thursday, November, 14th. The company reported ($0.18) earnings per share for the quarter, topping the Zacks' consensus estimate of ($0.25) by $0.07. View Motus GI's Earnings History.

When is Motus GI's next earnings date?

Motus GI is scheduled to release their next quarterly earnings announcement on Wednesday, March 25th 2020. View Earnings Estimates for Motus GI.

What price target have analysts set for MOTS?

2 Wall Street analysts have issued 1 year price targets for Motus GI's stock. Their forecasts range from $6.00 to $10.00. On average, they anticipate Motus GI's share price to reach $7.67 in the next twelve months. This suggests a possible upside of 212.9% from the stock's current price. View Analyst Price Targets for Motus GI.

What is the consensus analysts' recommendation for Motus GI?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Motus GI in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Motus GI.

Has Motus GI been receiving favorable news coverage?

Media headlines about MOTS stock have been trending somewhat negative on Thursday, InfoTrie Sentiment Analysis reports. InfoTrie ranks the sentiment of news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Motus GI earned a media sentiment score of -1.7 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for Motus GI.

Are investors shorting Motus GI?

Motus GI saw a increase in short interest in October. As of October 31st, there was short interest totalling 1,530,000 shares, an increase of 9.3% from the September 30th total of 1,400,000 shares. Based on an average daily trading volume, of 69,800 shares, the short-interest ratio is presently 21.9 days. Approximately 7.2% of the company's shares are sold short. View Motus GI's Current Options Chain.

Who are some of Motus GI's key competitors?

What other stocks do shareholders of Motus GI own?

Who are Motus GI's key executives?

Motus GI's management team includes the folowing people:
  • Mr. Timothy P. Moran, CEO & Director (Age 47)
  • Mr. Mark Pomeranz, Pres, COO & Director (Age 58)
  • Mr. Andrew Lawrence Taylor, Chief Financial Officer (Age 48)

When did Motus GI IPO?

(MOTS) raised $21 million in an initial public offering on Wednesday, February 14th 2018. The company issued 3,500,000 shares at $5.00-$7.00 per share. Piper Jaffray served as the underwriter for the IPO and Oppenheimer & Co. was co-manager.

Who are Motus GI's major shareholders?

Motus GI's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Trellus Management Company LLC (0.71%) and Millennium Management LLC (0.53%). Company insiders that own Motus GI stock include Andrew Lawrence Taylor, David P Hochman, Gary E Jacobs, Gary J Pruden, Larry N Feinberg, Life Sciences Maste Perceptive, Mark Pomeranz and Timothy P Moran. View Institutional Ownership Trends for Motus GI.

Which institutional investors are buying Motus GI stock?

MOTS stock was acquired by a variety of institutional investors in the last quarter, including Millennium Management LLC and Trellus Management Company LLC. Company insiders that have bought Motus GI stock in the last two years include Andrew Lawrence Taylor, David P Hochman, Gary E Jacobs, Gary J Pruden, Larry N Feinberg, Life Sciences Maste Perceptive, Mark Pomeranz and Timothy P Moran. View Insider Buying and Selling for Motus GI.

How do I buy shares of Motus GI?

Shares of MOTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Motus GI's stock price today?

One share of MOTS stock can currently be purchased for approximately $2.45.

How big of a company is Motus GI?

Motus GI has a market capitalization of $70.55 million and generates $40,000.00 in revenue each year. The company earns $-22,260,000.00 in net income (profit) each year or ($1.23) on an earnings per share basis. Motus GI employs 44 workers across the globe.View Additional Information About Motus GI.

What is Motus GI's official website?

The official website for Motus GI is http://www.motusgi.com/.

How can I contact Motus GI?

Motus GI's mailing address is 1301 EAST BROWARD BOULEVARD 3rd Floor, FT. LAUDERDALE FL, 33301. The company can be reached via phone at 954-541-8000 or via email at [email protected]


MarketBeat Community Rating for Motus GI (NASDAQ MOTS)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  126 (Vote Outperform)
Underperform Votes:  121 (Vote Underperform)
Total Votes:  247
MarketBeat's community ratings are surveys of what our community members think about Motus GI and other stocks. Vote "Outperform" if you believe MOTS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MOTS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/12/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel